| Literature DB >> 29982203 |
Hannah Lennon1,2, Scott Kelly3, Matthew Sperrin2, Iain Buchan2, Amanda J Cross4, Michael Leitzmann5, Michael B Cook3, Andrew G Renehan1,2,6.
Abstract
OBJECTIVES: Latent class trajectory modelling (LCTM) is a relatively new methodology in epidemiology to describe life-course exposures, which simplifies heterogeneous populations into homogeneous patterns or classes. However, for a given dataset, it is possible to derive scores of different models based on number of classes, model structure and trajectory property. Here, we rationalise a systematic framework to derive a 'core' favoured model.Entities:
Keywords: growth curves; growth mixture models; latent class models; lifetime obesity; trajectories
Mesh:
Year: 2018 PMID: 29982203 PMCID: PMC6042544 DOI: 10.1136/bmjopen-2017-020683
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Framework of eight steps to construct a latent class trajectory model
| Step | Step description | Criteria for selection |
| 1 | Scope model by provisionally selecting a plausible number of classes based on available literature and the structure based on plausible clinical patterns. | Examine linearity of the shape of standardised residual plots for each of the classes in a model with no random effects. |
| 2 | Refine the model from step 1 to confirm the optimal number of classes, typically testing K=1–7 classes. | Lowest Bayesian information criteria value. |
| 3 | Refine optimal model structure from fixed through to unrestricted random effects of the model using the favoured K derived in step 2. | |
| 4 | Run model adequacy assessments as described in online |
APPA: average of maximum probabilities should be greater than 70% for all classes. OCC values greater than 5.0. Relative entropy values greater than 0.5. |
| 5 | Investigate graphical presentation |
Plot mean trajectories across time for each class in a single graph. Plot mean trajectories with 95% predictive intervals for each class (one class per graph). Plot individual class ‘spaghetti plots’ across time for a random sample. |
| 6 | Run additional tools to assess discrimination including Degrees of separation (DoS) and Elsensohn’s envelope of residuals |
DoS greater than zero. Envelope of residuals is assessed in plots by observing clear separations between classes. |
| 7 | Assess for clinical characterisation and plausibility. |
Tabulation of characteristics by latent classes. Are the trajectory patterns clinically meaningful? Perhaps, consider classes with a minimum percentage of the population. Are the trajectory patterns clinically plausible? Concordance of class characteristics with those for other well-established variables. |
| 8 | Conduct sensitivity analyses, for example, testing models without complete data at all time points. | General assessment of patterns of trajectories compared with main model. |
Number of classes (K=1–7) using random effects quadratic structure model F (proportional covariance structure) by gender
| Model |
| Number of parameters | BIC | Proportions per class % | ||||||
| Class | Class II | Class III | Class IV | Class V | Class VI | Class VII | ||||
| Men | ||||||||||
| Model F | 1 | 10 | * | 100 | ||||||
| 2 | 15 | 3 324 009 | 83 | 17 | ||||||
| 3 | 20 | 3 310 908 | 62 | 32 | 3 | |||||
| 4 | 25 | 3 324 128 | 100 | 0 | 0 | 0 | ||||
| 5 | 30 | 68 | 25 | 4 | 3 | 0.4 | ||||
| 6 | 35 | * | ||||||||
| 7 | 40 | * | ||||||||
| Women | ||||||||||
| Model F | 1 | 10 | * | 100 | ||||||
| 2 | 15 | 2 195 386 | 86 | 14 | ||||||
| 3 | 20 | 2 179 080 | 58 | 34 | 8 | |||||
| 4 | 25 | 2 179 137 | 100 | 0 | 0 | 0 | ||||
| 5 | 30 | 2 169 791 | 41 | 32 | 21 | 4 | 2 | |||
| 6 | 35 | * | ||||||||
| 7 | 40 | * | ||||||||
Results from random effects quadratic structure model G (unrestricted) by gender are shown in supplemental material S2.
*Models failed to converge.
BIC, Bayesian information criteria.
Model adequacy assessments of latent trajectory class models based on different assumptions for K=5 classes, by gender in the NIH-AARP cohort
| Model | Description | BIC | Proportion per class % | Average posterior probability assignment | Relative | Degree of separation (DoSK) |
| Men | ||||||
| A | Homoscedastic | 3476322 | 51: 22: 21: 6: 1 | 83: 84: 85: 91: 95 | 0.78 | 0.10 |
| B | Heteroscedastic | 3511646 | 41: 26: 20: 7: 6 | 85: 82: 84: 89: 86 | - | 0.15 |
| C | Random intercept | 3364856 | 68: 24: 4: 3: 2 | 90: 82: 89: 85: 82 | 0.81 | 0.34 |
| D | Random slope | 3325463 | 63: 19: 13: 3: 4 | 72: 70: 74: 83: 83 | 0.59 | 0.26 |
| E | Random quadratic, Equal | |||||
| F | Random quadratic, Proportional | 68: 25: 4: 3: 0.4 | 81: 74: 87: 83: 74 | 0.68 | 0.36 | |
| G | Random quadratic, Unrestricted | 3320005 | 56: 30: 8: 5: 0.4 | 74: 70: 80: 79: 88 | 0.63 | 0.33 |
| Women | ||||||
| A | Homoscedastic | 2289509 | 45: 36: 13: 4: 1 | 90: 84: 88: 93: 96 | 0.83 | 0.14 |
| B | Heteroscedastic | 2238444 | 32: 30: 15: 15: 8 | 87: 83: 85: 89: 91 | - | 0.05 |
| C | Random intercept | 2240681 | 52: 35: 9: 2: 2 | 89: 82: 86: 89: 91 | 0.79 | 0.21 |
| D | Random slope | 2193155 | 79: 12: 5: 2: 2 | 91: 80: 79: 86: 91 | 0.82 | 0.34 |
| E | Random quadratic, Equal | 2188224 | 95: 5: 0: 0: 0 | 49: 88: 0: 0: 0 | 0.26 | 0.05 |
| F | Random quadratic, Proportional | 41: 33: 21: 3: 2 | 74: 79: 80: 83:84 | 0.66 | 0.09 | |
| G | Random quadratic, Unrestricted | 2187707 | 67: 23: 6: 3: 1 | 84: 77: 84:82: 87 | 0.73 | 0.34 |
*Failed to converge.
BIC, Bayesian information criteria; NIH, National Institutes of Health.
Bold values are the chosen according to the lowest value.
Figure 1BMI mean trajectories by men (left) and women (right) for models A–G. Colours are used to discriminate classes within each plot but should not be used for direct comparisons across plots. BMI, body mass index.
Figure 2Illustration of the local (Elsensohn) residual envelope plots (shown here for model B).
Latent class characteristics of 177 453* men and 111 503* women in the NIH-AARP cohort
| Model F (favoured model) | |||||
| Class I | Class II | Class III | Class IV | Class V | |
| Stable normal weight | Normal weight to overweight | Normal weight to obese | Overweight to obese | Rapid increase to obese | |
| Number, n (%) | 120 867 (68.1) | 44 383 (25.0) | 6 723 (3.8) | 4 764 (2.7) | 718 (0.4) |
| Mean (SD) BMI at 18 years | 20.75 (0.01) | 23.92 (0.02) | 21.69 (0.04) | 27.16 (0.09) | 24.76 (0.2) |
| Mean (SD) BMI at 35 years | 23.35 (0.01) | 26.72 (0.01) | 30.24 (0.04) | 26.61 (0.09) | 37.69 (0.26) |
| Mean (SD) BMI at 50 years | 24.66 (0.01) | 29.12 (0.02) | 31.34 (0.05) | 30.95 (0.12) | 35.01 (0.35) |
| Mean (SD) entry age, years | 62.88 (0.01) | 61.59 (0.03) | 62.03 (0.06) | 59.71 (0.07) | 57.73 (0.18) |
| Mean (SD) current (at baseline) BMI, kg/m2 | 25.39 (0.01) | 30.84 (0.02) | 29.07 (0.05) | 35.14 (0.12) | 30.51 (0.28) |
| Mean (SD) waist circumference, cm | 94.38 (0.02) | 106.23 (0.05) | 102.73 (0.13) | 115.24 (0.28) | 105.91 (0.64) |
| Smoking, n (%) | |||||
| Current | 11 823 (10) | 3 761 (8) | 638 (9) | 460 (10) | 106 (15) |
| Former | 67 948 (56) | 26 898 (61) | 3 809 (57) | 3 002 (63) | 370 (52) |
| Never | 37 149 (31) | 12 130 (27) | 2 012 (30) | 1 110 (23) | 218 (30) |
| Missing | 3 946 (3) | 1 594 (4) | 264 (4) | 191 (4) | 24 (3) |
| Mean (SD) alcohol g/day | 18.69 (0.13) | 17.45 (0.21) | 15.48 (0.56) | 15.57 (0.69) | 10.22 (1.14) |
| Number, n (%) | 36 311 (32.6) | 45 832 (41.1) | 23 544 (21.1) | 3 898 (3.5) | 1 918 (1.7) |
| Mean (SD) entry age, years | 62.48 (0.03) | 62.23 (0.02) | 61.07 (0.03) | 59.61 (0.09) | 59.69 (0.12) |
| Mean (SD) BMI at 18 years | 19.3 (0.01) | 20.44 (0.01) | 22.61 (0.02) | 29.01 (0.09) | 23.97 (0.1) |
| Mean (SD) BMI at 35 years | 20.26 (0.01) | 22.53 (0.01) | 25.51 (0.02) | 28.38 (0.1) | 36.92 (0.16) |
| Mean (SD) BMI at 50 years | 21.16 (0.01) | 24.77 (0.01) | 29.52 (0.03) | 33.51 (0.13) | 37.69 (0.2) |
| Mean (SD) current (at baseline) BMI, kg/m2 | 21.97 (0.01) | 26.66 (0.01) | 32.4 (0.03) | 37.47 (0.15) | 34.4 (0.19) |
| Mean (SD) waist circumference, cm | 76.19 (0.04) | 86.66 (0.05) | 97.82 (0.09) | 106.29 (0.32) | 101.96 (0.41) |
| Smoking, n (%) | |||||
| Current | 5803 (16) | 5660 (12) | 2733 (12) | 495 (13) | 214 (11) |
| Former | 14 173 (39) | 18 557 (40) | 9748 (41) | 1764 (45) | 731 (38) |
| Never | 15 313 (42) | 20 290 (44) | 10 417 (44) | 1507 (39) | 909 (47) |
| Missing | 1022 (3) | 1325 (3) | 646 (3) | 132 (3) | 64 (3) |
| Mean (SD) alcohol g/day | 8.07 (0.1) | 6.26 (0.08) | 4.47 (0.11) | 3.92 (0.29) | 3.4 (0.48) |
| Hormone therapy use, n (%) | |||||
| Ever | 13 989 (39) | 20 206 (44) | 12 215 (52) | 2241 (57) | 1092 (57) |
| Never | 22 322 (61) | 25 626 (56) | 11 329 (48) | 1657 (43) | 826 (43) |
*Exclusions include 35 women and 2 men with biologically implausible cancers from classes in proportions (2, 16, 12, 0 and 5) and (1, 0, 0, 1 and 0), respectively.
BMI, body mass index; NIH, National Institutes of Health.
Concurrence between BMI categories and classes in model F from the NIH-AARP cohort
| Latent class | N | BMI categories (kg/m2) | ||||
| <18.5 | 18.5 to 24.9 | 25.0 to 29.9 | 30.0 to 34.9 | >35.0 | ||
| Men | ||||||
| 177 453 | 875 | 53 466 | 86 967 | 28 234 | 7911 | |
| I | 120 866 | 312 | 50 171 | 68 646 | 1736 | 1 |
| II | 44 383 | 319 | 1860 | 14 097 | 23 472 | 4635 |
| III | 6723 | 47 | 859 | 3335 | 1943 | 539 |
| IV | 4763 | 172 | 437 | 679 | 917 | 2558 |
| V | 718 | 25 | 139 | 210 | 166 | 178 |
| Cohen | ||||||
| Women | ||||||
| 111 503 | 1327 | 48 273 | 36 025 | 16 245 | 9633 | |
| I | 36 311 | 1215 | 33 371 | 1725 | 0 | 0 |
| II | 45 832 | 3 | 12 584 | 28 636 | 4607 | 2 |
| III | 23 544 | 83 | 1683 | 4777 | 10 587 | 6414 |
| IV | 3898 | 14 | 382 | 519 | 614 | 2369 |
| V | 1918 | 12 | 253 | 368 | 437 | 848 |
| Cohen | ||||||
K weighted.
BMI, body mass index; NIH, National Institutes of Health.